Amy C Shurtleff
Affiliation: Walter Reed Army Medical Center
- Bioterrorism and emerging infectious disease - antimicrobials, therapeutics and immune-modulators. SARS coronavirusAmy C Shurtleff
US Army Medical Research Institute of Infectious Diseases, Virology Division, Fort Detrick, Frederick, MD 21702 5011, USA
IDrugs 7:91-5. 2004..Finally, approaches to circumventing and directing the immune response using genetic engineering will be reported...
- TMC-114 (Tibotec)Amy C Shurtleff
Department of Molecular Virology, United States Army Medical Research Institute for Infectious Diseases, Fort Detrick, MD 21702, USA
Curr Opin Investig Drugs 5:879-86. 2004..Because of its improved antiviral and superior pharmacokinetic properties, TMC-114 was selected for clinical development. Phase II trials of TMC-114 are underway...
- Development of a new vaccine for the prevention of Lassa feverThomas W Geisbert
Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA
PLoS Med 2:e183. 2005..Currently, there are no licensed vaccines for Lassa fever, and no experimental vaccine has completely protected nonhuman primates against a lethal challenge...
- Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenavirusesTove C Bolken
SIGA Technologies Inc, 4575 SW Research Way, Corvallis, OR 97333, USA
Antiviral Res 69:86-97. 2006..This series of compounds represent a new class of inhibitors that may warrant further development for potential inclusion in a strategic stockpile...